S5 the Prevalence of Self-Reported Erectile Dysfunction Among Urological Cases in Turkish Men

Bayraktar, Zeki; Atun, Ihsan

doi:10.1016/s1569-9056(11)61447-4

Cited by 4 publications

(7 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In population-or clinicbased samples patients are identified by systematic screening using tools ⁄ scales such as the IPSS and IIEF which may lead to higher case ascertainment, while administrative claims may be hampered by coding practices that limit the number of diagnoses that can be recorded or list diagnoses in a hierarchical manner. Overall, prevalence rates reported in studies using scales ⁄ methods other than the IPSS and IIEF were generally lower than those reported using these validated scales, whereas studies using medical record diagnosis codes or claims databases reported the lowest prevalence rates (27)(28)(29). This suggests that the validated IPSS and IIEF have greater sensitivity for identifying BPH ⁄ LUTS and ED compared with other assessment tools or claims.…”

Section: Discussionmentioning

confidence: 89%

“…More than 100,000 study subjects from different geographic regions (Brazil, Germany, Iran, Italy, the Netherlands, Nigeria, the UK, and the US) participated in urology clinic‐based studies. Four studies involved men presenting to the clinic with ED (18,19,28,29), while seven studies identified men who presented with LUTS (20–22,30–33).…”

Section: Resultsmentioning

confidence: 99%

“…Treatment‐seeking men for ED were assessed using electronic medical records or administrative claims data. In a study using electronic medical records of 9780 men (mean age 42) who presented at a Turkish urology polyclinic, LUTS symptoms, identified by ICD‐10 codes, in men with self‐reported ED were present in 2.3% (28). In a study using administrative claims data, among men (mean age 57) identified with ED either by an ICD‐9 code for a medical visit for ED or by prescription for a PDE‐5 inhibitor ( n = 81,659), the reported prevalence rate of LUTS was 8% and the reported prevalence rate of BPH was 1.5% (29).…”

Section: Resultsmentioning

confidence: 99%

“…Furthermore, one of the most widely used questionnaires to identify BPH/LUTS – the IPSS – does not assess all domains of LUTS symptoms, which may have led to underestimation of the condition. All men in this review of 23 studies had LUTS, but 10 studies (21,23,28–35) specifically identified LUTS associated with BPH. The prevalence of coexisting BPH/LUTS and ED within each category seemed largely similar to unspecified LUTS and ED.…”

Section: Discussionmentioning

confidence: 99%

“…articles (23 from PubMed, 0 from EMBASE and 0 from Cochrane) that reported on the prevalence of both male-LUTS and ED were identified for data extraction and are the focus of this review. Twelve studies used both the IPSS and IIEF as assessment tools (1,(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24), whereas 11 used alternative approaches (1,(25)(26)(27)(28)(29)(30)(31)(32)(33)(34). Eleven studies were cross-sectional (1,(14)(15)(16)(17)(18)20,(22)(23)(24)(25), seven were reported as prospective (19,21,(30)(31)(32)(33)(34), two studies reported retrospectively from BPH registries (24,35) and three reported retrospectively using medical record or prescription claims databases (27)(28)(29).…”

Section: Methodsmentioning

confidence: 99%

See 4 more Smart Citations

Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data

Seftel¹,

Rosette

Birt³

et al. 2012

International Journal of Clinical Practice

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 89%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 3 more Smart Citations

Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data

Seftel¹,

Rosette

Birt³

et al. 2012

International Journal of Clinical Practice

View full text Add to dashboard Cite

show abstract

Variations in the Number of Patients Presenting With Andrological Problems During the Coronavirus Disease 2019 Pandemic and the Possible Reasons for These Variations: A Multicenter Study

et al. 2020

View full text Add to dashboard Cite

Introduction COVID-19 pandemic caused unprecedented restrictions in outpatient services and surgical practices in urology as in other medical branches as well as in all areas of life. Aim To investigate whether there have been variations in the presentations of male patients with sexual and reproductive health problems to the outpatient urology clinics during the COVID-19 pandemic and to understand the underlying factors for these variations, if any. Methods Male patients aged ≥18 years who presented to the outpatient urology clinics in 12 centers across Turkey from February 1, 2020 to June 1, 2020 were retrospectively evaluated. The patients were divided into two groups: those who presented to the outpatient clinic from February 1, 2020 to March 11, 2020 comprised the “pre-COVID-19 pandemic period” group, whereas those who presented to the outpatient clinic from March 12, 2020 to June 1, 2020 comprised the “COVID-19 pandemic period” group and compared with each other. Main Outcome Measures Number and diagnose of patients presented to urology outpatient clinics Results Andrological problems were detected in 721 of 4,955 male patients included in the study. During the COVID-19 pandemic period, there was a significant increase in andrological diagnosis in these patients compared with the pre-COVID-19 pandemic period [n=293 (17%) vs. n=428 (13.2%), p<0.001, respectively]. Similarly, there was a statistically significant increase in the number of patients diagnosed with male reproductive or sexual health problems during the COVID-19 pandemic period [n=107 (6.2%) vs. n=149 (4.6%), p=0.016 and n=186 (10.8%) vs. n=279 (8.6%), p=0.013, respectively]. The number of patients diagnosed with erectile dysfunction during the pandemic was also significantly higher than the pre-COVID-19 pandemic period [n=150 (8.7%) vs. n=214 (6.6%), p=0.008]. Conclusion Presentations to the outpatient urology clinics due to andrological problems markedly increased during the pandemic period. Although these problems are of multifactorial origin, psychogenic factors are also considered to significantly trigger these problems.

show abstract

Abnormal Cytokine Profile in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome and Erectile Dysfunction

Bouloukaki

Papadimitriou

Sofras

et al. 2014

Mediators of Inflammation

View full text Add to dashboard Cite

Patients with obstructive sleep apnea-hypopnea syndrome (OSAHS) show a high prevalence of erectile dysfunction (ED). Although the underlying pathogenesis is still unknown, endothelial dysfunction, induced by inflammatory cytokines, chemokines, and adhesion molecules, has been proposed as a possible mechanism. The aim of this study was to assess whether OSAHS is associated with activation of the inflammatory cytokine system in patients with ED compared to the matched OSAHS patients with normal sexual function. Thirty-one patients with severe OSAHS and ED were included. Fifteen patients with severe OSAHS and without ED served as controls. Serum concentrations of high-sensitivity C-reactive protein (hsCRP), tumor necrosis factor-α (TNF-a), interleukin-6 (IL-6), interleukin-8 (IL-8), and adiponectin were measured after the diagnostic polysomnography. We found that hsCRP levels were significantly elevated in OSAHS patients with ED compared to controls. Similarly, TNF-a levels, IL-6, and IL-8 were elevated in OSAHS patients with ED compared to controls. Serum adiponectin levels were lower in OSAHS-ED patients, but the difference did not reach statistical significance. The presence of ED in patients with severe OSAHS is associated with elevated levels of inflammatory markers, underlining a possible involvement of endothelial dysfunction in the pathogenesis of ED.

show abstract

S5 the Prevalence of Self-Reported Erectile Dysfunction Among Urological Cases in Turkish Men

Cited by 4 publications

References 26 publications

Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data

Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data

Variations in the Number of Patients Presenting With Andrological Problems During the Coronavirus Disease 2019 Pandemic and the Possible Reasons for These Variations: A Multicenter Study

Abnormal Cytokine Profile in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome and Erectile Dysfunction

Contact Info

Product

Resources

About